Genome Engineering for Humanity
PIPELINE
HM-002
Monoclonal antibody
HM-002
Solid tumors
- Oncology
- Discovery stage
- Stromal modulator
-
Indications
Solid tumors
-
Mechanism of Action
HM-002 is a fully human monoclonal antibody that is developed from our SynThese™ platform. The Fc engineering with a newly added protein function enhance antibody performance, specifically for malignant tumors with an extremely dense stroma deposition around the lesions.
-
Development status
This early discovery asset is currently set for preclinical studies. HuMab initiated a collaborative research with multiple research institutes with medical unmet needs in therapeutic interventions targeting pancreatic cancer.